BMSN.OB: Summary for BIO-MATRIX SCIENTIFI - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 7:51am EST - Canadian Markets open in 1 hour and 39 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Bio-Matrix Scientific Group, Inc. (BMSN.OB)

On Feb 9: 0.065 USD 0.00 (0.00%)

MORE ON BMSN.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BIO-MATRIX SCIENTIFI (OTC BB:BMSN.OB) Delayed quote data

Last Trade:	0.065 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.065
Open:	N/A
Bid:	0.057 x 5000
Ask:	0.076 x 5000
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.05 - 0.33
Volume:	0
Avg Vol (3m):	112,267
Market Cap:	3.14M
P/E (ttm):	N/A
EPS (ttm):	-0.076
Div & Yield:	N/A (N/A%)

Bio-Matrix Scientific Group, Inc. (BMSN.OB)

1d 5d 3m 6m 1y 2y 5y

Add BMSN.OB to Portfolio

Download Data

HEADLINES

•	BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Tue 6:00am)

•	Bio-Matrix Scientific Group's Majority Owned Subsidiary Entest BioMedical Initiates Studies to Support Stem Cell / Laser Regenerative Therapy for COPD
	Marketwire (Tue, Feb 2)

•	Bio-Matrix Scientific Group, Inc.'s Majority Owned Subsidiary Entest BioMedical, Inc. to Be Featured on Stem Cell Pioneers "Ask the Doctor" Forum Discussing the Company's Progress on Its COPD Stem Cell / Laser Therapy
	Marketwire (Thu, Jan 28)

•	Entest BioMedical Projecting Near Term Start Up of Study on Stem Cell and Laser Treatment for COPD at Bio-Matrix Scientific Group's Stem Cell Research Facility
	Marketwire (Fri, Jan 22)

•	BIO-MATRIX SCIENTIFIC GROUP, INC. Financials
	EDGAR Online Financials (Wed, Jan 20)

•	BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 10-K, Annual Report
	EDGAR Online (Thu, Jan 14)

•	Entest BioMedical Inc. (OTCBB: ENTB) Obtains Specimen to Be Used in Immunotherapeutic Cancer Vaccine Research
	Marketwire (Tue, Jan 12)

•	BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
	EDGAR Online (Fri, Jan 8)

•	BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant
	EDGAR Online (Tue, Jan 5)

•	Entest BioMedical Files Grant Application With the National Heart, Lung and Blood Institute for Development of the Company's ENT-576 Laser Device for Treatment of COPD
	Marketwire (Wed, Dec 30)

More Headlines for BMSN.OB...

BUSINESS SUMMARY

Bio-Matrix Scientific Group, Inc., a development stage company, engages in the design, development, and marketing of medical devices, specifically disposable instruments in the United Sates.

Full Company Profile

Add to Portfolio

Email to a Friend

•